PTH Antibody (monoclonal anti human)

Description

PTH Antibody
Catalog number: B2010224
Lot number: Batch Dependent
Expiration Date: Batch dependent
Volume/Weight: 50 ug
pH: na
Supplied as: Ready-to-use
Appearance: Solution
Applications: High purity monoclonal antibody to human Parathyroid hormone (PTH). This antibody has been validated in ELISA, IHC, WB and other immunoassay applications.
Storage: -20C
Keywords: Antibody to human PTH, parathyroid hormone antibody
Grade: Biotechnology grade. All components are highly pure (minimum 99%). All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered on a 0.22 um.

References:
1: Soliman M, Hassan W, Yaseen M, Rao M, Sawaya BP, El-Husseini A. PTH assays in
dialysis patients: Practical considerations. Semin Dial. 2019 Jan;32(1):9-14.

2: Suarez-Bregua P, Cal L, Cañestro C, Rotllant J. PTH Reloaded: A New
Evolutionary Perspective. Front Physiol. 2017 Oct 9;8:776.

3: Smit MA, van Kinschot CMJ, van der Linden J, van Noord C, Kos S. Clinical
Guidelines and PTH Measurement: Does Assay Generation Matter? Endocr Rev. 2019
Dec 1;40(6):1468-1480.

4: Zangari M, Yoo H, Shin I, Kim B, Edmondson R, Morgan GJ, Suva LJ, Yoon D.
Thymic PTH Increases After Thyroparathyroidectomy in C57BL/KaLwRij Mice.
Endocrinology. 2018 Apr 1;159(4):1561-1569.

5: Ursem SR, Vervloet MG, Hillebrand JJG, de Jongh RT, Heijboer AC. Oxidation of
PTH: in vivo feature or effect of preanalytical conditions? Clin Chem Lab Med.
2018 Jan 26;56(2):249-255.

6: Holten-Andersen L, Pihl S, Rasmussen CE, Zettler J, Maitro G, Baron J, Heinig
S, Hoffmann E, Wegge T, Krusch M, Faltinger F, Killian S, Sprogoe K, Karpf DB,
Breinholt VM, Cleemann F. Design and Preclinical Development of TransCon PTH, an
Investigational Sustained-Release PTH Replacement Therapy for
Hypoparathyroidism. J Bone Miner Res. 2019 Nov;34(11):2075-2086.

7: Sakai S, Hongo H, Yamamoto T, Hasegawa T, Takeda S, Saito H, Endo K, Yogo K,
Amizuka N. Sequential Treatment with Eldecalcitol After PTH Improves Bone
Mechanical Properties of Lumbar Spine and Femur in Aged Ovariectomized Rats.
Calcif Tissue Int. 2019 Mar;104(3):251-261.

8: Kritmetapak K, Pongchaiyakul C. Parathyroid Hormone Measurement in Chronic
Kidney Disease: From Basics to Clinical Implications. Int J Nephrol. 2019 Sep
17;2019:5496710.

9: Xiao L, Fei Y, Hurley MM. FGF2 crosstalk with Wnt signaling in mediating the
anabolic action of PTH on bone formation. Bone Rep. 2018 Sep 21;9:136-144.

10: Huimin C, Ying C, Changying X, Xiaoming Z, Yan Z, Qingting W, Haoyang M,
Lina Z, Ming Z, Guang Y, Xiaolin L, Purrunsing Y, Ningning W. Effects of
Parathyroidectomy on Plasma iPTH and (1-84) PTH Levels in Patients with Stage 5
Chronic Kidney Disease. Horm Metab Res. 2018 Oct;50(10):761-767.

11: Forssmann WG, Tillmann HC, Hock D, Forssmann K, Bernasconi C, Forssmann U,
Richter R, Hocher B, Pfützner A. Pharmacokinetic and Pharmacodynamic
Characteristics of Subcutaneously Applied PTH-1-37. Kidney Blood Press Res.
2016;41(5):507-518.

12: Goodman WG, Jüppner H, Salusky IB, Sherrard DJ. Parathyroid hormone (PTH),
PTH-derived peptides, and new PTH assays in renal osteodystrophy. Kidney Int.
2003 Jan;63(1):1-11.

Products Related to PTH Antibody: Biochemical Buffers and Solutions